<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121135">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02058771</url>
  </required_header>
  <id_info>
    <org_study_id>UHL10824: ULTIMATE</org_study_id>
    <nct_id>NCT02058771</nct_id>
  </id_info>
  <brief_title>Utilising Lifemap to Investigate Malignant Arrhythmia Therapy</brief_title>
  <acronym>ULTIMATE</acronym>
  <official_title>ULTIMATE: Utilising Lifemap to Investigate Malignant Arrhythmia ThErapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals, Leicester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals, Leicester</source>
  <oversight_info>
    <authority>United Kingdom: National Health Service</authority>
    <authority>United Kingdom: National Institute for Health Research</authority>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is universally recognised that current methods for risk stratification of sudden cardiac
      death (SCD) are limited. A novel SCD risk marker, the Regional Restitution Instability Index
      (R2I2), measures the degree of heterogeneity in electrical restitution using data obtained
      from a standard 12 lead ECG acquired during an invasive electrophysiological study.

      In an ischaemic cardiomyopathy (ICM) cohort of 66 patients, an R2I2 of â‰¥1.03 identified
      subjects with a significantly higher risk of ventricular arrhythmia (VA) or death (43%)
      compared with those with an R2I2 &lt;1.03 (11%) (P=0.004).

      This study will use non-invasive techniques to acquire electrical restitution data: exercise
      and pharmacological stress, and will incorporate body surface potential mapping to develop a
      non-invasive and high-resolution form of R2I2. Suitable patients will be recruited into a
      prospective, observational study.

      HYPOTHESES:

      PRIMARY:

        1. R2I2 is predictive of ventricular arrhythmia (VA) / SCD in patients with ICM.

        2. The exercise stress protocol will create a dynamic range of heart rates that allows ECG
           quantification of electrical restitution heterogeneity that correlates with invasive
           R2I2 and is predictive of VA/SCD. The pharmacological stress protocol will create a
           dynamic range of heart rates that allows ECG based quantification of electrical
           restitution heterogeneity that correlates with invasive R2I2 and is predictive of
           VA/SCD.

      SECONDARY:

        1. A high-resolution electrical map acquired using body surface potential mapping will
           correlate with R2I2 and these data can be included in the R2I2 calculation to improve
           its prediction of SCD/VA.

        2. Serial measurement of R2I2 will produce consistent values.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Ventricular arrhythmia/Sudden cardiac death</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Syncope</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ischemic Cardiomyopathy</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Implantable Defibrillator User</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>Ischaemic cardiomyopathy</arm_group_label>
    <description>Patients with ischaemic cardiomyopathy attending for ICD implantation</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fresh Frozen Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ischaemic cardiomyopathy attending for ICD implantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18

          -  History of ischaemic cardiomyopathy

        Exclusion Criteria:

          -  Unable to give informed consent

          -  &lt;28 days since cardiac surgery or acute coronary syndrome
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G. Andre Ng, MBChB, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leicester</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>M. Shoaib Siddiqui, MBBS</last_name>
    <phone>+44 116 258 3643</phone>
    <email>mss33@le.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Will B Nicolson, MBChB</last_name>
    <email>wbn1@le.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NIHR Leicester Cardiovascular Biomedical Research Unit</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Shoaib Siddiqui, MBBS</last_name>
      <phone>+44 116 258 3643</phone>
      <email>mss33@le.ac.uk</email>
    </contact>
    <investigator>
      <last_name>G. Andre Ng, MBChB, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Will B Nicoloson, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>M. Shoaib Siddiqui, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 7, 2014</lastchanged_date>
  <firstreceived_date>February 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Action potential duration restitution</keyword>
  <keyword>Ventricular arrhythmia</keyword>
  <keyword>Sudden cardiac death</keyword>
  <keyword>Body-surface potential mapping</keyword>
  <keyword>Electrocardiogram</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
